Roth Capital Reaffirms Buy Rating for Stereotaxis (NYSEAMERICAN:STXS)

Stereotaxis (NYSEAMERICAN:STXS)‘s stock had its “buy” rating reissued by Roth Capital in a note issued to investors on Wednesday,Benzinga reports. They presently have a $4.00 price objective on the stock. Roth Capital’s price target points to a potential upside of 66.32% from the stock’s current price.

Separately, UBS Group set a $4.00 target price on Stereotaxis in a report on Wednesday, November 5th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $4.00.

Stereotaxis Trading Down 15.6%

STXS traded down $0.45 during midday trading on Wednesday, hitting $2.41. 1,457,150 shares of the company were exchanged, compared to its average volume of 467,189. The company’s 50 day simple moving average is $2.96 and its 200 day simple moving average is $2.53. The firm has a market capitalization of $219.02 million, a price-to-earnings ratio of -8.26 and a beta of 1.65. Stereotaxis has a 1-year low of $1.54 and a 1-year high of $3.59.

Institutional Trading of Stereotaxis

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of Stereotaxis by 4.2% in the third quarter. Vanguard Group Inc. now owns 3,441,091 shares of the company’s stock valued at $10,702,000 after buying an additional 138,482 shares in the last quarter. Essex Investment Management Co. LLC grew its stake in Stereotaxis by 3.5% in the 3rd quarter. Essex Investment Management Co. LLC now owns 1,598,114 shares of the company’s stock valued at $4,970,000 after acquiring an additional 53,358 shares during the period. Geode Capital Management LLC increased its holdings in Stereotaxis by 0.9% in the 2nd quarter. Geode Capital Management LLC now owns 1,478,201 shares of the company’s stock worth $3,135,000 after acquiring an additional 13,891 shares in the last quarter. Warberg Asset Management LLC raised its position in Stereotaxis by 260.1% during the second quarter. Warberg Asset Management LLC now owns 1,201,500 shares of the company’s stock worth $2,547,000 after acquiring an additional 867,878 shares during the period. Finally, Prescott Group Capital Management L.L.C. raised its position in Stereotaxis by 44.5% during the second quarter. Prescott Group Capital Management L.L.C. now owns 1,139,252 shares of the company’s stock worth $2,415,000 after acquiring an additional 350,600 shares during the period. 45.35% of the stock is owned by institutional investors and hedge funds.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.